Occult primary head and neck squamous cell carcinoma: Utility of discovering primary lesions

Otolaryngology - Head and Neck Surgery (United States)

Volumn 151, Issue 2, 2014, Pages 272-278

  Davis, Kara S ^a   Byrd, J Kenneth ^a   Mehta, Vikas ^b   Chiosea, Simon I ^a   Kim, Seungwon ^a   Ferris, Robert L ^a   Johnson, Jonas T ^a   Duvvuri, Umamaheswar ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Louisiana State University Health Sciences Center at Shreveport   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

base of tongue; cervical metastases; HPV; human papilloma virus; oropharyngeal; oropharyngeal cancer; squamous cell carcinoma; tonsil; unknown primary; unknown primary tumor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PRIMARY TUMOR; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TIME TO RECURRENCE; WART VIRUS; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; ISOLATION AND PURIFICATION; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PAPILLOMAVIRIDAE; PATHOLOGY; SURVIVAL RATE; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; PAPILLOMAVIRIDAE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84904908920     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599814533494     Document Type: Article

References (20)

1. Haas I, Hoffman TK, Engers R, Ganzer U. Diagnostic strategies in cervical carcinoma of an unknown primary. Eur Arch Otorhinolaryngol. 2002 ; 259: 325-333
2. Karni RJ, Rich JT, Sinha P, Haughey BH. Transoral laser microsurgery: a new approach for unknown primaries of the head and neck. Laryngoscope. 2011 ; 121: 1194-1201
3. Strojan P, Ferlito A, Medina JE, et al. Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck. 2013 ; 35: 123-132
4. Mehta V, Johnson P, Tassler A, et al. A new paradigm for the diagnosis and management of unknown primary tumors of the head and neck: a role for transoral robotic surgery. Laryngoscope. 2013 ; 123: 146-151
5. El-Mofty SK, Zhang MQ, Davila RM. Histologic indentification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma. Head Neck Pathol. 2008 ; 2: 163-168
6. Ang K, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010 ; 363: 24-35
7. Begum S, Gillison ML, Ansari-Lari MA, et al. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res. 2003 ; 9: 6469-6475
8. McQuone SJ, Eisele DW, Lee D, et al. Occult tonsillar carcinoma in the unknown primary. Laryngoscope. 1998 ; 108: 1605-1610
9. Goldenberg D, Begum S, Westra WH, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck. 2008 ; 30: 898-903
10. Issing WJ, Taleban B, Tauber S. Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Otorhinolaryngol. 2003 ; 260: 436-443
11. Fakhry C, Westra W, Li S, et al. Improved survival of patients with human papilloma - positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008 ; 100: 261-269
12. Marur S, D'souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010 ; 11: 781-789
13. Compton AM, Moore-Medlin T, Herman-Ferdinandez L, et al. Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma. Otolaryng Head Neck. 2011 ; 145: 51-57
14. Kong CS, Narasimhan B, Cao H, et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 2009 ; 74: 553-561
15. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 2008 ; 26: 3138-3146
16. Lassen P. The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome. Radiother Oncol. 2010 ; 95: 371-380
17. Kimple RJ, Smith MA, Blitzer GC, et al. Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res. 2013 ; 73: 4791-4800
18. Chen AM, Li J, Beckett LA, et al. Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer. Laryngoscope. 2013 ; 123: 152-157
19. Williams R, Lee DW, Elzey BD, et al. Preclinical models of HPV+ and HPV- HNSCC in mice: an immune clearance of HPV+ HNSCC. Head Neck. 2009 ; 31: 911-918
20. Rietbergen MM, Braakhuis BJM, Moukhtari N, et al. No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors. J Oral Pathol Med. 2014 ; 43: 137-142